Back
ProShares UltraShort QQQ Vs. Corcept Therapeutics Industry Stock Comparison
Buy
66
QID
ProShares UltraShort QQQ
Last Price:
$47.50
Seasonality Move:
-8.37%
Buy
52
CORT
Corcept Therapeutics
Last Price:
$70.59
Seasonality Move:
6.42%
Buy
66
ProShares UltraShort QQQ (QID)
is a Buy
Is ProShares UltraShort QQQ a Buy, Sell or Hold?
-
The current ProShares UltraShort QQQ [QID] share price is $45.79. The Score for QID is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
QID is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $74.65. The Score for CORT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QID Stock Price Chart
What is ProShares UltraShort QQQ's stock price today?
-
The ProShares UltraShort QQQ share price today is $45.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QID is experiencing buying pressure, which is a positive indicator for future bullish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $74.65The current trend is moderately bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
QID Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.22 | Buy |
| Relative Strength Index (14 RSI): | 75.98 | Buy |
| Chaikin Money Flow: | -1064459 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 20.64 | Buy |
| Relative Strength Index (14 RSI): | 54.3 | Buy |
| Chaikin Money Flow: | 841196 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
QID Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.91 | Buy |
| 20-day SMA: | 38.05 | Buy |
| 50-day SMA: | 34.43 | Buy |
| 200-day SMA: | 35.75 | Buy |
| 8-day EMA: | 41.01 | Buy |
| 20-day EMA: | 38.36 | Buy |
| 50-day EMA: | 35.79 | Buy |
| 200-day EMA: | 37.53 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 78.72 | Sell |
| 20-day SMA: | 65.73 | Buy |
| 50-day SMA: | 64.92 | Buy |
| 200-day SMA: | 49.1 | Buy |
| 8-day EMA: | 74.01 | Buy |
| 20-day EMA: | 53.91 | Buy |
| 50-day EMA: | 29.29 | Buy |
| 200-day EMA: | 8.68 | Buy |
ProShares UltraShort QQQ Earnings Growth & QID Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.
ProShares UltraShort QQQ Technical Analysis
| Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||